Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C29H38N8O8 |
| Molecular Weight | 626.6608 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12C[C@@]3([H])C(C(=O)C4=C(C=CC=C4O)[C@@]3(C)O)=C(O)[C@]1(O)C(=O)C(C(=O)NCN5CCN(CC5)C(=N)NC(N)=N)=C(O)[C@H]2N(C)C
InChI
InChIKey=DIRJDIBCAHCCFL-AQFAATAFSA-N
InChI=1S/C29H38N8O8/c1-28(44)13-5-4-6-16(38)17(13)21(39)18-14(28)11-15-20(35(2)3)22(40)19(24(42)29(15,45)23(18)41)25(43)33-12-36-7-9-37(10-8-36)27(32)34-26(30)31/h4-6,14-15,20,38,40-41,44-45H,7-12H2,1-3H3,(H,33,43)(H5,30,31,32,34)/t14-,15-,20-,28+,29-/m0/s1
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Preliminary report: electron microscopical appearance of human bronchial epithelium after long-term treatment with guamecycline by aerosol route. | 1969 |
|
| Guamecycline and the bronchopulmonary system. Measurement of antibiotic levels in bronchial secretion. | 1969 Oct |
|
| [Effects of aerosol administration of guamecycline in patients with broncho-pulmonary diseases]. | 1971 Jan-Feb |
|
| [Inhibiting effects of guamecycline and of tetracycline hydrochloride on antibody-producing cells of the spleen and lymph nodes]. | 1971 Jan-Mar |
|
| Guamecycline in bronchial infections due to Diplococcus pneumoniae. | 1972 Jan-Feb |
|
| [Guamecycline in the treatment of acute pneumopathies. Clinical research and comparison with other tetracyclines]. | 1972 Nov 21 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C1595
Created by
admin on Sat Dec 16 16:21:22 GMT 2023 , Edited by admin on Sat Dec 16 16:21:22 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
4NQR4R6G3S
Created by
admin on Sat Dec 16 16:21:22 GMT 2023 , Edited by admin on Sat Dec 16 16:21:22 GMT 2023
|
PRIMARY | |||
|
C001312
Created by
admin on Sat Dec 16 16:21:22 GMT 2023 , Edited by admin on Sat Dec 16 16:21:22 GMT 2023
|
PRIMARY | |||
|
SUB07977MIG
Created by
admin on Sat Dec 16 16:21:22 GMT 2023 , Edited by admin on Sat Dec 16 16:21:22 GMT 2023
|
PRIMARY | |||
|
C90947
Created by
admin on Sat Dec 16 16:21:22 GMT 2023 , Edited by admin on Sat Dec 16 16:21:22 GMT 2023
|
PRIMARY | |||
|
240-611-1
Created by
admin on Sat Dec 16 16:21:22 GMT 2023 , Edited by admin on Sat Dec 16 16:21:22 GMT 2023
|
PRIMARY | |||
|
m1182
Created by
admin on Sat Dec 16 16:21:22 GMT 2023 , Edited by admin on Sat Dec 16 16:21:22 GMT 2023
|
PRIMARY | Merck Index | ||
|
16545-11-2
Created by
admin on Sat Dec 16 16:21:22 GMT 2023 , Edited by admin on Sat Dec 16 16:21:22 GMT 2023
|
PRIMARY | |||
|
Xanthomycin A
Created by
admin on Sat Dec 16 16:21:22 GMT 2023 , Edited by admin on Sat Dec 16 16:21:22 GMT 2023
|
PRIMARY | |||
|
100000084450
Created by
admin on Sat Dec 16 16:21:22 GMT 2023 , Edited by admin on Sat Dec 16 16:21:22 GMT 2023
|
PRIMARY | |||
|
CHEMBL2103960
Created by
admin on Sat Dec 16 16:21:22 GMT 2023 , Edited by admin on Sat Dec 16 16:21:22 GMT 2023
|
PRIMARY | |||
|
3273
Created by
admin on Sat Dec 16 16:21:22 GMT 2023 , Edited by admin on Sat Dec 16 16:21:22 GMT 2023
|
PRIMARY | |||
|
DTXSID301043159
Created by
admin on Sat Dec 16 16:21:22 GMT 2023 , Edited by admin on Sat Dec 16 16:21:22 GMT 2023
|
PRIMARY | |||
|
2705
Created by
admin on Sat Dec 16 16:21:22 GMT 2023 , Edited by admin on Sat Dec 16 16:21:22 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
